Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Dec 1;12(6):956-959.
doi: 10.21037/hbsn-23-548. Epub 2023 Nov 9.

Up-to-date global epidemiology of nonalcoholic fatty liver disease

Affiliations
Editorial

Up-to-date global epidemiology of nonalcoholic fatty liver disease

Richie Manikat et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Metabolic dysfunction-associated steatotic liver disease (MASLD); mortality; nonalcoholic fatty liver disease (NAFLD); nonalcoholic steatohepatitis (NASH); prevalence.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-548/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 2023;77:1335-47. 10.1097/HEP.0000000000000004 - DOI - PMC - PubMed
    1. Konyn P, Ahmed A, Kim D. Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease. Clin Mol Hepatol 2023;29:S43-57. 10.3350/cmh.2022.0351 - DOI - PMC - PubMed
    1. Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2022;7:851-61. 10.1016/S2468-1253(22)00165-0 - DOI - PubMed
    1. Zou ZY, Shen B, Fan JG. Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1764-72. 10.1093/ibd/izz043 - DOI - PubMed
    1. Ye Q, Zou B, Yeo YH, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020;5:739-52. 10.1016/S2468-1253(20)30077-7 - DOI - PubMed